Valsartan

Type: Keyphrase

Name: Valsartan

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Japan Medical Group To Prevent Repeats Of Tainted Novartis Diovan Trials

The Japanese Association of Medical Sciences has called a meeting to discuss ways to improve the nation's process of clinical trials in the wake of revelations Novartis studies of its Diovan (valsartan) blood-pressure drug may have been tainted. ... [Published The Rose Sheet - May 20 2013]

Entities: Diovan, Novartis AG, Japan, Valsartan

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Ranbaxy Laboratories Ltd

Another Ranbaxy Mystery: What Happened To Valsartan?

Ranbaxy’s valsartan application may have been held back after FDA detected lapses at the company’s new manufacturing site in Mohali, India, according to sources, but the beleaguered company has a plan to move forward. ... [Published The Rose Sheet - May 16 2013]

Entities: Valsartan, Ranbaxy Laboratories Ltd, Mohali (India), Beleaguered

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Patent Issued for Solid Dosage Forms of Valsartan, Amlodipin. . .

Patent Issued for Solid Dosage Forms of Valsartan, Amlodipine and Hydrochlorothiazide and Method of Making the SamePharmaceutical CompaniesNewsRx.comBy a News Reporter-Staff News Editor at Diabetes Week -- Novartis Pharmaceuticals Corporation (East Hanover, ... [Published Equities.com - May 15 2013]

Entities: Amlodipine/valsartan, Hydrochlorothiazide, Valsartan

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Testing Meds: Companies Look Overseas for Cheap Subjects

For years, major pharmaceutical companies have been testing new drugs in developing countries like India. The practice is forbidden, but the use of subcontractors makes it difficult to detect.In 2008, the Indian Uday Foundation published a controversial ... [Published Spiegel Online - May 14 2013]

Entities: Drugs, Valsartan, Cheap

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Novartis AG

Ex-professor suspected of covering up drug firm employee's involvement in clinical test

Former Kyoto Prefectural University of Medicine professor Hiroaki Matsubara is suspected of ordering his subordinates not to list the name of an employee of Novartis Pharma K.K. on papers for a clinical test conducted by his team on the industry giant's ... [Published MAINICHI Daily News - May 14 2013]

Entities: Novartis AG, Clinical trials, Matsubara (Japan)

First reported May 14 2013 - Updated May 14 2013 - 2 reports

VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film Coated VALSARTAN AND HYDROCHLOROTHIAZIDEtablet [Macleods Pharmaceuticals Limited]

Updated Date: May 9, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]

Entities: Valsartan, Hydrochlorothiazide

First reported May 09 2013 - Updated May 09 2013 - 2 reports

VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film Coated VALSARTAN AND HYDROCHLOROTHIAZIDEtablet [Macleods Pharmaceuticals Limited]

Updated Date: May 9, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]

Entities: Valsartan, Hydrochlorothiazide

First reported May 06 2013 - Updated May 06 2013 - 1 reports

France: Ex Parte injunctions and SPCs

Ex parte injunctions are extremely rare in patent infringement cases in France. The Paris Court of Appeal rendered an interesting ruling in that respect on 11 December 2012.BackgroundNovartis AG was the holder of European Patent EP 0 443 983 which expired ... [Published Bird & Bird - May 06 2013]

Entities: Ex Parte, Sanofi SA, Injunction, Novartis AG, Valsartan

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Japanese Research Scandal Expands To A Second Trial And A Novartis Employee

A Japanese research scandal, which has so far centered on actions taken by the once-prominent cardiologist Hiroaki Matsubara, has now expanded. As has been previously reported, several papers authored by Matsubara have been retracted, including, most ... [Published Forbes.com - May 02 2013]

Entities: Novartis AG, Valsartan, Kyoto, Yui (singer), Matsubara (Japan)

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Drug company employee was involved in more suspicious university tests

An employee of a pharmaceutical company listed as being involved with university clinical tests for one of the company's drugs conducted similar research at three additional universities, a company representative has confirmed.The employee belongs to ... [Published MAINICHI Daily News - May 02 2013]

Entities: Valsartan, Nagoya University, Shiga University of Medical Science, Chiba University

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Swiss drug company begins investigation into suspicious clinical test

Swiss global pharmaceutical company Novartis has begun an investigation using outside experts into a clinical test on one of its drugs, the company's Japanese branch revealed on April 24.The probe comes due to complaints that the Japanese subsidiary's ... [Published MAINICHI Daily News - Apr 25 2013]

Entities: Novartis AG, Clinical trials, Kyoto Prefectural University of Medicine, Valsartan, Osaka City University

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

Japan School To Probe Allegation Novartis Employee Part Of Diovan Trials

A pair of Japan clinical trials of the Novartis blood pressure drug Diovan (valsartan) are being investigated after it was discovered an employee of the Swiss-based company headed statistical analysis in both. ... [Published The Rose Sheet - Apr 25 2013]

Entities: Diovan, Novartis AG, Japan, Allegation

Quotes

From the background information supplied by the inventors, news correspondents obtained the following quote: "The present invention is directed to solid dosage formulations containing a combination of valsartan amlodipine and a diuretic such as hydrochlorothiazide, as well as to methods of making such solid dosage forms and a method of treating a subject with such solid dosage forms."

Patent Issued for Solid Dosage Forms of Valsartan, Amlodipin. . . [Published Equities.com - May 15 2013]

...The compound was produced by the Swiss manufacturer Novartis. The company denies all culpability in the deaths. "The children that participated in the tests were very ill. It cannot be determined that administering Valsartan was the causecause of death for any of these patients" says Novartis spokesman Michael Schiendorfer...

Testing Meds: Companies Look Overseas for Cheap Subjects [Published Spiegel Online - May 14 2013]

More Content

sort by: Date \| Relevance
Japan Medical Group To Prevent Repeats Of Taint... [Published The Rose Sheet - May 20 2013]
Invisible enemy [Published thestar.com.my - May 19 2013]
Lotus Pharmaceuticals, Inc. - Pharmaceuticals &... [Published TransWorldNews - May 18 2013]
Another Ranbaxy Mystery: What Happened To Valsa... [Published The Rose Sheet - May 16 2013]
Patent Issued for Solid Dosage Forms of Valsart... [Published Equities.com - May 15 2013]
Testing Meds: Companies Look Overseas for Cheap... [Published Spiegel Online - May 14 2013]
Local candidates make one last push for votes [Published Kelowna Daily Courier - May 14 2013]
Ex-professor suspected of covering up drug firm... [Published MAINICHI Daily News - May 14 2013]
VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film C... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film C... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Suspicions Raised About Another Japanese Cardio... [Published Forbes.com - May 10 2013]
VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film C... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
VALSARTAN AND HYDROCHLOROTHIAZIDEtablet, Film C... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Endo Reports First Quarter Financial Results [Published Freshnews.com - May 07 2013]
Endo Reports First Quarter Financial Results PR... [Published Yahoo! Finance - May 07 2013]
France: Ex Parte injunctions and SPCs [Published Bird & Bird - May 06 2013]
Japanese Research Scandal Expands To A Second T... [Published Forbes.com - May 02 2013]
Drug company employee was involved in more susp... [Published MAINICHI Daily News - May 02 2013]
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Othe... [Published InsiderMonkey.com - May 02 2013]
Sean Ison [Published Ozaukee Press - May 01 2013]
Michael Kallaur [Published Ozaukee Press - May 01 2013]
Investing in Biotech Companies? Know These Names! [Published Motley Fool - Apr 30 2013]
Committee for Free Expression Director Héctor B... [Published Hondurasweekly - Apr 29 2013]
Police Strike in Honduras [Published Hondurasweekly - Apr 29 2013]
Massive Cocaine Bust in Venezuela Highlights Sc... [Published Hondurasweekly - Apr 29 2013]
JTF-Bravo and Honduran Police Inspire Tomorrow’... [Published Hondurasweekly - Apr 29 2013]
Novartis speaks out after second kickbacks lawsuit [Published Pharma Times - Apr 29 2013]
"Congestive Heart Failure (Heart Failure) - Pip... [Published Live-PR.com - Apr 28 2013]
Geological Faults Caused Earthquakes in Honduras [Published Hondurasweekly - Apr 28 2013]
Swiss drug company begins investigation into su... [Published MAINICHI Daily News - Apr 25 2013]